Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bifidobacterium Longum
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of the Effects of a Bifidobacterial Strain on Bowel Movement in Healthy Adults
Details : B. Longum is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
November 13, 2024
Lead Product(s) : Bifidobacterium Longum
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bifidobacterium Longum
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Syneos Health | Medidata Solutions | McMaster University | CaligorRx, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Bifidobacterium Longum is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 23, 2021
Lead Product(s) : Bifidobacterium Longum
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Syneos Health | Medidata Solutions | McMaster University | CaligorRx, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable